Highlights
MWC network plays key role in national response to COVID-19 pandemic
Investigators from across the Centre have been instrumental in developing the tools necessary to track and trace the virus, i...
read the full story
Pilin protein may combat the hairy problem of human pathogens
MWC investigations into the puzzle of a nanoscopic skyscraper – ‘the pilus’ – have sparked separate lines of research into no...
read the full story
MWC technical excellence helps NZ attract new medicines
A high profile paper has highlighted the growing support the MWC is providing to NZ’s burgeoning clinical trials sector.
read the full story
Nationwide research flagship takes fight to global viral threats
A growing network of Maurice Wilkins Centre investigators around New Zealand are collaborating on research to tackle importa...
read the full story
Developing a vaccine to prevent rheumatic fever
Group A Streptococcus (GAS) infection is widespread around the world, but causes particularly serious complications in New Ze...
read the full story
Mid-term review sets future direction
A comprehensive independent assessment found the Centre to be performing at a high level, producing distinct and positive ben...
read the full story
Smarter drug design
An advanced experimental technique linked to high powered computation is becoming an increasingly important tool for MWC rese...
read the full story
High-impact publications highlight TB research
Researchers in the MWC’s Tuberculosis Flagship Research Programme have had their long hours in the lab recognised through pub...
read the full story
Investigating a bacterial 'master' of disguise
MWC researchers have revealed a unique protein in a common bacterium that helps it disguise itself from immune attack. This d...
read the full story
Re-thinking the causes of rheumatic fever
Researchers and health professionals are re-thinking the causes of rheumatic fever after studies by Maurice Wilkins Centre in...
read the full story
Early career researchers zoom in on an important drug target
An estimated 1.3 million people die from tuberculosis (TB) each year, and new drugs are desperately needed, especially as res...
read the full story
New Zealand TB research tackles international problem
A 2014 pilot study funded by the Maurice Wilkins Centre’s Flexible Research Programme has led to a larger investigation into ...
read the full story
Advancing a vaccine for rheumatic fever (2013)
In 2013 the Maurice Wilkins Centre hosted a symposium attended by world experts in rheumatic fever. It marked the start of a ...
read the full story
Stepping up the fight: The Tuberculosis Flagship (2013)
The Maurice Wilkins Centre is behind the launch of a national research network of ‘serious intellectual muscle’ that aims to ...
read the full story
PhD student part of international drug development programme (2012)
Maurice Wilkins Centre-funded PhD student Matthew Bull is part of international research on a new class of immunosuppressants...
read the full story
New Zealand TB drug candidate selected (2012)
In late 2012 a promising New Zealand compound targeting treatment-resistant tuberculosis (TB) was selected as a drug candidat...
read the full story
Rheumatic fever - Research strengths confront national need (2012)
The Maurice Wilkins Centre prioritises rheumatic fever research, and its work built momentum in 2012 with the appointment of ...
read the full story
New inhibitor for tuberculosis (2011)
A new way to shut down the bacterium responsible for tuberculosis has been devised by researchers in one of the Maurice Wilki...
read the full story